The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Guido Dalbagni

Division of Urology

Memorial Sloan-Kettering Cancer Center

New York

NY 10021



Name/email consistency: high



  • Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. 2001 - 2009
  • Department of Urology, Division of Epidemiology and Biostatistics, the Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, USA. 2006
  • Urology Service, Department of Surgery, Laboratories of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, USA. 1997


  1. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Dalbagni, G., Vora, K., Kaag, M., Cronin, A., Bochner, B., Donat, S.M., Herr, H.W. Eur. Urol. (2009) [Pubmed]
  2. Can excretory urography detect upper urinary tract tumors after radical cystectomy for urothelial cancer?. Dalbagni, G. Nature Clinical Practice. Urology (2008) [Pubmed]
  3. The management of superficial bladder cancer. Dalbagni, G. Nature Clinical Practice. Urology (2007) [Pubmed]
  4. Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. Dalbagni, G., Russo, P., Bochner, B., Ben-Porat, L., Sheinfeld, J., Sogani, P., Donat, M.S., Herr, H.W., Bajorin, D. J. Clin. Oncol. (2006) [Pubmed]
  5. Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder. Dalbagni, G., Russo, P., Sheinfeld, J., Mazumdar, M., Tong, W., Rabbani, F., Donat, M.S., Herr, H.W., Sogani, P., dePalma, D., Bajorin, D. J. Clin. Oncol. (2002) [Pubmed]
  6. Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study. Dalbagni, G., Ren, Z.P., Herr, H., Cordon-Cardo, C., Reuter, V. Clin. Cancer Res. (2001) [Pubmed]
  7. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Dalbagni, G., Han, W., Zhang, Z.F., Cordon-Cardo, C., Saigo, P., Fair, W.R., Herr, H., Kim, N., Moore, M.A. Clin. Cancer Res. (1997) [Pubmed]
WikiGenes - Universities